SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.17 Cr | ₹3.46 Cr | ₹5.62 Cr | ₹5.62 Cr | ₹1.57 Cr |
What is the latest Contingent Liabilities ratio of SUPRIYA LIFESCIENCE ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4.17 Cr |
| Mar2024 | ₹3.46 Cr |
| Mar2023 | ₹5.62 Cr |
| Mar2022 | ₹5.62 Cr |
| Mar2021 | ₹1.57 Cr |
How is Contingent Liabilities of SUPRIYA LIFESCIENCE Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.17 Cr | 20.41 | |
| Mar2024 | ₹3.46 Cr | -38.45 | |
| Mar2023 | ₹5.62 Cr | 0.00 | |
| Mar2022 | ₹5.62 Cr | 257.96 | |
| Mar2021 | ₹1.57 Cr | - | |
Compare Contingent Liabilities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹6,969.3 Cr | -14.9% | -9.1% | 42.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | -14.9% |
-9.1% |
42.4% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses